Abstract Objective-To determine the incidence of infection after implantation of a cardioverter-defibrillator and the management of this complication.
(>37.5°C), and leucocytosis (>10 000/ml) with or without purulent drainage. Five patients (38%) had infections during the first implantation, whereas eight patients (62%) had infections after replacement of the pulse generator. Early infection was observed in four patients (31%) and late infection in nine (69%). Incidence of infection was higher in patients who underwent epicardial cardioverter-defibrillator implantation (12/207 patients, 5 .8%) than in those who received nonthoracotomy lead systems (11125 patients, 0.8%) (P < 0-05). Infections were caused by staphyloccocus in 10 patients, pseudomonas in two patients, and streptococcus in one patient. The whole device had to be removed in all patients. During a mean foliow up of 39 (29) months seven patients died: six of congestive heart failure and one ofmyocardial reinfarction. Conclusions-Infection, one of the most serious complications after cardioverterdefibrillator implantation, is associated with increased morbidity and mortality. When infection occurs the system must be removed to avoid a fatal outcome.
No other therapeutic approach is better at preventing sudden cardiac death than implantation of an automatic implantable cardioverter-defibrillator.'-3 The use of cardioverter-defibrillators has increased exponentially, more than 25 000 patients having received this device during the past 12 years. 4 Despite excellent results in preventing sudden death there are few reports about complications due to operative mortality, electrodes, or other causes.'-' Infection is one of the most serious complications and is associated with morbidity, prolonged stay in hospital, and death.8 We report on the infection rate, diagnosis, management, and follow up in 335 patients who had a cardioverter-defibrillator implanted over a period of 10 years.
Patients and methods
PATIENTS
We followed up 335 consecutive patients (304 males and 31 females, mean age 56 (11) 62%) compared with patients with first cardioverter-defibrillator implantation (5 of 13 patients, 38%). Early infection (within 1 month) occurred in four out of 13 patients (31%). In contrast, nine out of 13 patients (69%) had late (>1 month) infection. Infections occurred in 12 out of 207 patients (5 8%) who underwent epicardial implantation compared with one of the 125 patients (0 8%) who received non-thoracotomy defibrillation lead systems (P < 0-05).
CLINICAL FINDINGS
Infections were associated with fever (>37 5°C) in 11 of the 13 patients (85%) and leucocytosis (>10 000/ml) in 12 of them (92%). All had blood cultures positive for micro-organisms. Infections were localised in the pulse generator pocket in all of them. These findings led to the diagnosis of infection. Pathological findings around the defibrillator patch electrodes (fluid around the patches) were present in one patient (8%), but this patient also had purulent drainage of the pulse generator pocket. In all patients clinical findings were, without any doubt, that of infection.
TREATMENT
On admission all patients were treated immediately by systemic antibiotics. However, in all patients it was necessary to remove the cardioverter-defibrillator system within a mean of 3 (2) days (range <1 to 7 days) after admission. In 12 of the 13 patients (92%) the electrodes and the pulse generator were removed, and in one patient (8%) with circumscribed pathological findings around the pocket, the pulse generator was removed but the electrodes were not. After removal of the entire cardioverter-defibrillator system, systemic antibiotic treatment was continued for three to four weeks and followed by oral antibiotics for at least three months. One to three months after removal patients were considered for repeated device implantation if they had no signs of inflammation. (29) The incidence of any type of perioperative infection ranged from 0 to 16%, and infections due to the hardware of the implanted device hardware occurred in 0-7-2% of patients. [19] [20] [21] [22] [23] We found an overall infection rate of 3 9%. We found that infections occurred more commonly after replacement of the pulse generator than after first implantation of a cardioverter-defibrillator system. Late infection was more common than early infection after device implantation or pulse generator replacement. In addition, it is important to note that infections occurred significantly less often in patients with non-thoracotomy devices (0-8%) than in those after epicardial cardioverter-defibrillator implantation (5 8%) (P < 0 05).
PATHOGENESIS OF INFECTIONS
The pathogenesis of infection is still unclear, but it seems reasonable to divide it into early or late occurrence. Early infection, like pacemaker infections, is most commonly caused by staphylococci, which is in agreement with previous data.7 Contamination of the device by bacteria possibly occurs during the operation and infection may therefore appear soon after implantation. However, this is influenced by other factors such as the number and virulence of micro-organisms and factors influencing the host's defence. 24 Infections occurred late and after replacement of a pulse generator in most of our patients. The pathogenesis of late infection is either bacteriaemia or delayed onset of infection acquired soon after surgery. However, another possible explanation for late infection and a high infection rate after replacement of pulse generators might be the formation of fibrous tissue around the pulse generator with decreased circulation.25 DIAGNOSIS Diagnosis of infection is usually possible from local or general signs of inflammation, or both. However, it is sometimes difficult to decide whether a manifest infection is present, particularly if local pathological findings around the pulse generator (fluctuation) are present without fever, leucocytosis, or purulent drainage. In patients with suspected infection adequate management is difficult. 78 We found that clinical variables such as fever, leucocytosis, a shift of the differential count to the left, and positive blood culture were present and pointed to infection without the need for other diagnostic procedures.
The role of diagnostic methods such as echocardiography, chest radiography, computer tomography, and gallium scintigraphy in diagnosing infections of the device is controversial.202627 In cases of suspected infection "crumpling" (deformation of the radiopaque wire marker around the patch perimeter) of one or both patch-electrodes may occur7; in another study, however crumpling was observed in 21% of patch electrodes in 51 patients with an uncomplicated clinical course after implantation of a cardioverter-defibrillator.
The use of gallium scintigraphy to detect infection has been suggested by Kelly et al, who found that the technique detected all cases of infected devices in their patients. 20 However, Bakker et al described false positive results in non-infected healing wounds.8 Therefore, a final conclusion about the value of this method is not possible at the moment.
Computed tomography is helpful in identifying patients with problems after cardioverter-defibrillator implantation.7 28 However, detection of infection by this method is often difficult and fluid often occurs around patch electrodes after implantation, particularly within the perioperative period.22 Fluid collects between patch electrodes and epicardium in 4-5% of patients and is an unusual finding.8 TREATMENT There are several possible treatments for infections occurring after implantation of a cardioverter-defibrillator or replacement of a pulse generator: drug treatment (courses of systemic antibiotics), removal of the pulse generator in combination with drug treatment, and complete removal of the cardioverter-defibrillator system (electrode leads and pulse generator).
Although it may occasionally be possible to treat infected devices with systemic antibiotic drug treatment, we favour removal of the complete system, as suggested by others. 8 We believe that removal of the cardioverter-defibrillator system will cure infection and will avoid serious complications such as sepsis and death. We found that mortality in patients with infections after cardioverter-defibrillator implantation is high. Therefore, if infections occur the hardware should be removed immediately. We believe that systemic antibiotics will not cure infection in these patients and that antibiotics should be used before and after removal of the cardioverter-defibrillator system. We strongly recommend not delaying removal of the device because drug treatment will not prevent sepsis or death. However, conservative treatment in addition to removal of only the pulse generator may be successful in selected cases.29 CLINICAL IMPLICATIONS Infection is one of the most serious complications of cardioverter-defibrillators. If infection occurs, morbidity, mortality, and stay in hospital increase. In general, occurrence of infections after implantation is fairly low, particularly after implanting transvenous defibrillation lead systems. Infection leads to clinical signs of inflammation and local findings of warmth and erythema with or without purulent drainage. There is an increased risk after replacement of a pulse generator, infections more often being delayed. Therefore, patients need to be surveyed to avoid infection. If infection occurs they should be treated immediately. We believe that systemic antibiotics are only adjunctive treatment; patients who develop infections after having a cardioverter-defibrillator implanted should have all the hardware removed as soon as possible to avoid further complications or death.
